Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a publication entry for LEAP-005 colorectal cancer results with the full author list; updated the revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T23:52:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of conditions, and the page revision was updated to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-11T13:59:19.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces the prior v3.4.0; no user-facing content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T10:16:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Glossary visibility has been added and new timestamp fields such as Results First Posted and Last Update Posted were introduced, while older timestamp labels and No FEAR Act data were removed and the revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:10:51.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4; no changes to study data, eligibility criteria, locations, or results.
    Difference
    0.0%
    Check dated 2026-01-14T02:35:01.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Locations (study sites) have been updated with numerous new entries across various countries and regions. This expands the geographic reach of the trial.
    Difference
    3%
    Check dated 2025-12-23T17:15:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.